Haematological Disorders Paediatrics
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants with early stage (Ficat I-III) avascular necrosis of femoral head (Ficat, 1985) who have been diagnosed to have sickle cell disease. The Ficat staging is the most widely used for classification of AVNFH. 2. Children and adolescents who are aged 9 – 18 years.
Exclusion criteria
Exclusion criteria: 1. Participants with a history of severe motor disability (Alvarado, Ward, Muntz, Thompson, Rodeghier, Fernhall et al, 2015) that will have major impact on daily activities (e.g. stroke, musculoskeletal problems). 2. Participants with a concurrent condition other than sickle cell disease that predisposed them to the development of avascular necrosis of the femoral head (e.g., a history of chronic systemic steroid use or alcoholism). 3. Participants that have had crises for at least 1 month and blood transfusion three months prior to intervention (Dedeken et al, 2014). This is to prevent vasooclussive crises. 4. Participants who are not ambulant since some of the activities involve walking. 5. Participants without hip pain. 6. Patients on hydroxyurea: Hydroxyurea is a drug that reduces the frequency of painful episodes in SCD patients. It raises the level of Fetal Heamoglobin (HbF) and the haemoglobin level to about 50%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain | — |
Secondary
| Measure | Time frame |
|---|---|
| Range of motion, functional capacity, activities of daily, contractures, muscle power and quality of life, | — |
Countries
Nigeria
Contacts
Senior Lecturer Department of Physiotherapy Bayero University Kano